The Jaguar car brand faced renewed backlash over its “woke" modernist direction after designs for a new pink all-electric ...

Jaguar has unveiled its "Type 00" concept car after a controversial rebranding campaign some critics called "woke." It's ...

A car fire shut down parts of the Rickenbacker Causeway on Tuesday during peak morning traffic, tying up traffic to and from ...

The hot pink car is a first look at Jaguar's new generation of EVs, along with a metallic blue partner. They are both low and ...

He also remarked on the theme in the on-screen caption, “This was a miracle that no one got hurt,” given the havoc that a ...

NEW ROCHELLE -- A motorist was fatally injured in a single-car crash Tuesday on the Hutchinson River Parkway. The incident ...

12月2日，CAR-T细胞疗法概念上涨2.39%，今日主力资金流入1.57亿元，概念股20只上涨，2只下跌。 主力资金净流入居前的分别为药明康德（1.45亿元）、海南海药（6855.11万元）、智飞生物（3071.63万元）、香雪制药（2043.58万元）、中源协和（800.03万元）。

在当今医疗科技飞速发展的时代，CAR-T细胞疗法作为一种新兴的癌症治疗方式，因其高效和灵活性备受关注。然而，标价百万的CAR-T药物却在国家医保谈判中接连遭遇"折戟"，这背后究竟隐含着怎样的故事？

非霍奇金淋巴瘤（NHL）是一组淋巴造血系统恶性肿瘤的统称，其中以弥漫大B细胞淋巴瘤（DLBCL）最为常见。DLBCL病理类型复杂，临床亚型众多、可表现出不同的预后结局。对化疗敏感的复发/难治性DLBCL患者进行大剂量化疗后自体造血干细胞移植（HD-A ...

每年一度的医保谈判始终是业界翘首以待的盛事。自2018年国家医保局正式成立以来，国家医保局通过将创新药物以公允的价格及时纳入医保目录，以及支持其临床应用的加速等措施，极大地推动了创新药物的发展进程。